ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 215 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $36,000 | -30.8% | 914 | +0.9% | 0.01% | -25.0% |
Q2 2015 | $52,000 | -1.9% | 906 | +10.4% | 0.01% | 0.0% |
Q1 2015 | $53,000 | +12.8% | 821 | +7.7% | 0.01% | +14.3% |
Q4 2014 | $47,000 | +67.9% | 762 | +3.8% | 0.01% | +75.0% |
Q3 2014 | $28,000 | +33.3% | 734 | +6.8% | 0.00% | +33.3% |
Q2 2014 | $21,000 | -4.5% | 687 | +19.9% | 0.00% | 0.0% |
Q1 2014 | $22,000 | -15.4% | 573 | 0.0% | 0.00% | -25.0% |
Q4 2013 | $26,000 | +1200.0% | 573 | +839.3% | 0.00% | – |
Q3 2013 | $2,000 | – | 61 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |